Protection of mice against the lethal effects of sodium arsenite?A quantitative comparison of a number of chelating agents*1
- 1 December 1981
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 61 (3) , 385-392
- https://doi.org/10.1016/0041-008x(81)90360-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- TREATMENT OF LEAD POISONING BY 2,3-DIMERCAPTOSUCCINIC ACIDThe Lancet, 1978
- Treatment of Methyl Mercury Poisoning in Mice with 2,3‐Dimercaptosuccinic Acid and other Complexing ThiolsActa Pharmacologica et Toxicologica, 1978
- Treatment of methylmercury poisoning in the rat with sodium 2,3-dimercaptopropane-1-sulfonate: Influence of dose and mode of administrationToxicology and Applied Pharmacology, 1976
- Meso-dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoningJournal of Pharmacy and Pharmacology, 1976
- Acute systemic toxicity of pure dimercaprol and trimercaptopropaneToxicology and Applied Pharmacology, 1976
- Wilson's Disease with Reversible Renal Tubular DysfunctionAnnals of Internal Medicine, 1971
- Clinical uses of metal‐binding drugsClinical Pharmacology & Therapeutics, 1968
- N-ACETYL-DL-PENICILLAMINE, A NEW ORAL PROTECTIVE AGENT AGAINST THE LETHAL EFFECTS OF MERCURIC CHLORIDE1959
- Treatment of Schistosomiasis Mansoni with Antimony-a, a′-Dimercapto-Potassium Succinate (TWSb)The American Journal of Tropical Medicine and Hygiene, 1954
- Preparation and pharmacological properties of 4-hydroxymethyl-2-(3′-amino-4′-hydroxyphenyl)-1:3-dithia-2-arsacyclopentane (Mapharside-BAL compound)Biochemical Journal, 1947